Intracellular survival of Candida glabrata in macrophages: Immune evasion and persistence

FEMS Yeast Research

Volumn 15, Issue 5, 2015, Pages

  Kasper, Lydia ^a   Seider, Katja ^a   Hube, Bernhard ^a,b,c  

^a HANS KNÖLL INSTITUTE   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Candida glabrata; Immune evasion; Macrophage; Persistence; Replication; Survival

Indexed keywords

ANTIMICROBIAL ACTIVITY; CANDIDA GLABRATA; CELL ACTIVATION; HOST CELL; IMMUNE EVASION; MACROPHAGE; MATURATION; NUTRIENT LIMITATION; PHAGOCYTOSIS; PHAGOSOME; CANDIDIASIS; CELL SURVIVAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; MICROBIOLOGY; OXIDATIVE STRESS; PATHOGENICITY;

CANDIDA GLABRATA; CANDIDIASIS; CELL SURVIVAL; HUMANS; IMMUNE EVASION; MACROPHAGE ACTIVATION; MACROPHAGES; OXIDATIVE STRESS; PHAGOCYTOSIS; PHAGOSOMES;

EID: 84949217548     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1093/femsyr/fov042     Document Type: Short Survey

References (148)

1. Alvarez M, Casadevall A. Phagosome extrusion and hostcell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 2006;16:2161-5.
2. Arendrup M, Horn T, Frimodt-Moller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 2002;30:286-91.
3. Atanasova R, Angoulvant A, Tefit M, et al. Amousemodel for Candida glabrata hematogenous disseminated infection starting from the gut: evaluation of strains with different adhesion properties. PLoS One 2013;8:e69664.
4. Bain J, Gow NA, Erwig LP. Novel insights into host-fungal pathogen interactions derived from live-cell imaging. Semin Immunopathol 2015;37:131-9.
5. Bain JM, Lewis LE, Okai B, et al. Non-lytic expulsion/exocytosis of Candida albicans from macrophages. Fungal Genet Biol 2012;49:677-8.
6. Bain JM, Louw J, Lewis LE, et al. Candida albicans hypha formation and mannan masking of beta-glucan inhibit macrophage phagosome maturation. MBio 2014;5: e01874.
7. Bairwa G, Kaur R. A novel role for a glycosylphosphatidylinositolanchored aspartyl protease, CgYps1, in the regulation of pH homeostasis in Candida glabrata. Mol Microbiol 2011;79: 900-13.
8. Bliska JB, Casadevall A. Intracellular pathogenic bacteria and fungi-a case of convergent evolution? Nat Rev Microbiol 2009;7:165-71.
9. Bliven KA, Maurelli AT. Antivirulence genes: insights into pathogen evolution through gene loss. Infect Immun 2012;80:4061-70.
10. Bolotin-Fukuhara M, Fairhead C. Candida glabrata: a deadly companion? Yeast 2014;31:279-88.
11. Borah S, Shivarathri R, Srivastava VK, et al. Pivotal role for a tail subunit of the RNA polymerase II mediator complex CgMed2 in azole tolerance and adherence in Candida glabrata. Antimicrob Agents Ch 2014;58:5976-86.
12. Bourgeois C, Majer O, Frohner IE, et al. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr Opin Microbiol 2010;13:401-8.
13. Bourgeois C, Majer O, Frohner IE, et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling. J Immunol 2011;186:3104-12.
14. Brieland J, Essig D, Jackson C, et al. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun 2001;69:5046-55.
15. Briones-Martin-Del-Campo M, Orta-Zavalza E, Canas-Villamar I, et al. The superoxide dismutases of Candida glabrata protect against oxidative damage and are required for lysine biosynthesis, DNA integrity and chronological life survival. Microbiology 2015;161:300-10.
16. Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011;29:1-21.
17. Brown GD, Herre J, Williams DL, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003;197:1119-24.
18. Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 2013;15:701-8.
19. Brunke S, Quintin J, Kasper L, et al. Of mice, flies - and men? Comparing fungal infection models for large-scale screening efforts. Dis Model Mech 2015;8:473-86.
20. Brunke S, Seider K, Fischer D, et al. One small step for a yeast-microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation. PLoS Pathog 2014;10:e1004478.
21. Calcagno AM, Bignell E, Rogers TR, et al. Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. Yeast 2004;21:557-68.
22. Calcagno AM, Bignell E, Rogers TR, et al. Candida glabrata Ste11 is involved in adaptation to hypertonic stress, maintenance of wild-type levels of filamentation and plays a role in virulence. Med Mycol 2005;43:355-64.
23. Calcagno AM, Bignell E, Warn P, et al. Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation. Mol Microbiol 2003;50:1309-18.
24. Casadevall A. Evolution of intracellular pathogens. Annu Rev Microbiol 2008;62:19-33.
25. Castano I, Kaur R, Pan S, et al. Tn7-based genome-wide random insertionalmutagenesis of Candida glabrata. Genome Res 2003;13:905-15.
26. Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993;23:1034-8.
27. Charlier C, Nielsen K, Daou S, et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009;77:120-7.
28. Cheng S, Clancy CJ, Hartman DJ, et al. Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses. Infect Immun 2014;82:3015-22.
29. Cheng SC, Joosten LA, Kullberg BJ, et al. Interplay between Candida albicans and the mammalian innate host defense. Infect Immun 2012;80:1304-13.
30. Coco BJ, Bagg J, Cross LJ, et al. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 2008;23: 377-83.
31. Cormack BP, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 1999;285:578-82.
32. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Mic 2000;27:163-9.
33. Csank C, Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett 2000;189:115-20.
34. Cuellar-Cruz M, Briones-Martin-del-Campo M, Canas-Villamar I, et al. High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryot Cell 2008;7:814-25.
35. Cuellar-Cruz M, Lopez-Romero E, Ruiz-Baca E, et al. Differential response of Candida albicans and Candida glabrata to oxidative and nitrosative stresses. Curr Microbiol 2014;69:733-9.
36. de Groot PW, Kraneveld EA, Yin QY, et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 2008;7: 1951-64.
37. Dementhon K, El-Kirat-Chatel S, Noel T. Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes. PLoS One 2012;7:e32621.
38. Drummond RA, Saijo S, Iwakura Y, et al. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 2011;41:276-81.
39. Dujon B, Sherman D, Fischer G, et al. Genome evolution in yeasts. Nature 2004;430:35-44.
40. Ezekowitz RA, Sastry K, Bailly P, et al. Molecular characterization of the human macrophage mannose receptor: demonstration ofmultiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 1990;172:1785-94.
41. Fernandez-Arenas E, Bleck CK, Nombela C, et al. Candida albicans actively modulates intracellular membrane trafficking in mouse macrophage phagosomes. Cell Microbiol 2009;11: 560-89.
42. Ferrari S, Ischer F, Calabrese D, et al. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 2009;5:e1000268.
43. Ferrari S, Sanguinetti M, Torelli R, et al. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata. PLoS One 2011;6:e17589.
44. Fidel PL, Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96.
45. Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009;7:355-66.
46. Fukuda Y, Tsai HF, Myers TG, et al. Transcriptional profiling of Candida glabrata during phagocytosis by neutrophils and in the infected mouse spleen. Infect Immun 2013;81: 1325-33.
47. Gilbert AS, Wheeler RT, May RC. Fungal pathogens: survival and replication within macrophages. Cold Spring Harb Perspect Med 2014, DOI: 10.1101/cshperspect.a019661.
48. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002;111:927-30.
49. Haas A. The phagosome: compartmentwith a license to kill. Traffic 2007;8:311-30.
50. Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 2012;10: 525-37.
51. Hube B. Fungal adaptation to the host environment. Curr Opin Microbiol 2009;12:347-9.
52. Hybiske K, Stephens RS. Exit strategies of intracellular pathogens. Nat Rev Microbiol 2008;6:99-110.
53. Ifrim DC, Bain JM, Reid DM, et al. Role of Dectin-2 for host defense against systemic infection with Candida glabrata. Infect Immun 2014;82:1064-73.
54. Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012;336:1314-7.
55. Jacobsen ID, Brunke S, Seider K, et al. Candida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy. Infect Immun 2010;78:1066-77.
56. Jacobsen ID, Grosse K, Berndt A, et al. Pathogenesis of Candida albicans infections in the alternative chorio-allantoic membrane chicken embryomodel resembles systemicmurine infections. PLoS One 2011;6:e19741.
57. Jacobsen ID, Wilson D, Wachtler B, et al. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti-Infe 2012;10: 85-93.
58. Jandric Z, Schuller C. Stress response in Candida glabrata: pieces of a fragmented picture. Future Microbiol 2011;6:1475-84.
59. Jawhara S, Mogensen E, Maggiotto F, et al. Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of beta-mannosyltransferases. J Biol Chem 2012;287:11313-24.
60. Jayatilake JA, Samaranayake YH, Cheung LK, et al. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol Med 2006;35:484-91.
61. Jouault T, Ibata-Ombetta S, Takeuchi O, et al. Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis 2003;188:165-72.
62. Ju JY, Polhamus C, Marr KA, et al. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice. Antimicrob Agents Ch 2002;46: 1240-5.
63. Junqueira JC, Fuchs BB, Muhammed M, et al. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol 2011;11:247.
64. Kaloriti D, Tillmann A, Cook E, et al. Combinatorial stresses kill pathogenic Candida species. Med Mycol 2012;50: 699-709.
65. Kamran M, Calcagno AM, Findon H, et al. Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence. Eukaryot Cell 2004;3: 546-52.
66. Kasper L, Seider K, Gerwien F, et al. Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages. PLoS One 2014;9:e96015.
67. Kaur R, Domergue R, Zupancic ML, et al. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 2005;8:378-84.
68. Kaur R, Ma B, Cormack BP. A family of glycosylphosphatidy linositol-linked aspartyl proteases is required for virulence of Candida glabrata. P Natl Acad Sci USA 2007;104:7628-33.
69. Keppler-Ross S, Douglas L, Konopka JB, et al. Recognition of yeast by murine macrophages requires mannan but not glucan. Eukaryot Cell 2010;9:1776-87.
70. Klis FM, Boorsma A, DeGroot PW. Cell wall construction in Saccharomyces cerevisiae. Yeast 2006;23:185-202.
71. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:130.
72. Kraneveld EA, de Soet JJ, Deng DM, et al. Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia 2011;172:415-27.
73. Kuhn DM, Vyas VK. The Candida glabrata adhesin Epa1p causes adhesion, phagocytosis, and cytokine secretion by innate immune cells. FEMS Yeast Res 2012;12:398-414.
74. Li L, Dongari-Bagtzoglou A. Oral epithelium-Candida glabrata interactions in vitro. Oral Microbiol Immunol 2007;22:182-7.
75. Li L, Dongari-Bagtzoglou A. Epithelial GM-CSF induction by Candida glabrata. J Dent Res 2009;88:746-51.
76. Li L, Kashleva H, Dongari-Bagtzoglou A. Cytotoxic and cytokineinducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog 2007;42:138-47.
77. Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res 2007;86:204-15.
78. Linde J, Duggan S, Weber M, et al. Defining the transcriptomic landscape of Candida glabrata by RNA-Seq. Nucleic Acids Res 2015;43:1392-406.
79. Lionakis MS, Netea MG. Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog 2013;9:e1003079.
80. Lionakis MS, Swamydas M, Fischer BG, et al. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest 2013;123:5035-51.
81. Lorenz MC, Bender JA, Fink GR. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 2004;3:1076-87.
82. Ma H, May RC. Virulence in Cryptococcus species. Adv Appl Microbiol 2009;67:131-90.
83. Maccallum DM. Hosting infection: experimentalmodels to assay Candida virulence. Int J Microbiol 2012;2012:363764.
84. MacCallum DM, Castillo L, Brown AJ, et al. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One 2009;4:e6420.
85. MacCallum DM, Findon H, Kenny CC, et al. Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts. Infect Immun 2006;74:5244-8.
86. Mansour MK, TamJM, Khan NS, et al. Dectin-1 activation controls maturation of beta-1,3-glucan-containing phagosomes. J Biol Chem 2013;288:16043-54.
87. Medzhitov R, Janeway CA, Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-8.
88. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172:2731-8.
89. Miramon P, Kasper L, Hube B. Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immun 2013;202:183-95.
90. Miyazaki T, Inamine T, Yamauchi S, et al. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata. FEMS Yeast Res 2010a;10:343-52.
91. Miyazaki T, Nakayama H, Nagayoshi Y, et al. Dissection of Ire1 functions reveals stress response mechanisms uniquely evolved in Candida glabrata. PLoS Pathog 2013;9:e1003160.
92. Miyazaki T, Yamauchi S, Inamine T, et al. Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata. Antimicrob Agents Ch 2010b;54:1639-43.
93. Nakayama H, Ueno K, Uno J, et al. Growth defects resulting from inhibiting ERG20 and RAM2 in Candida glabrata. FEMS Microbiol Lett 2011;317:27-33.
94. Netea MG, Brown GD, Kullberg BJ, et al. An integrated model of the recognition of Candida albicans by the innateimmune system. Nat Rev Microbiol 2008;6:67-78.
95. Netea MG, Van Der Graaf CA, Vonk AG, et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002;185:1483-9.
96. Nevitt T. War-Fe-re: iron at the core of fungal virulence and host immunity. Biometals 2011;24:547-58.
97. Nevitt T, Thiele DJ. Host iron withholding demands siderophore utilization for Candida glabrata to survive macrophage killing. PLoS Pathog 2011;7:e1001322.
98. Ngo LY, Kasahara S, Kumasaka DK, et al. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J Infect Dis 2014;209:109-19.
99. Nunes P, Demaurex N, Dinauer MC. Regulation of the NADPH oxidase and associated ion fluxes during phagocytosis. Traffic 2013;14:1118-31.
100. Otto V, Howard DH. Further studies on the intracellular behavior of Torulopsis glabrata. Infect Immun 1976;14:433-8.
101. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007;45: 321-46.
102. Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 2012;125: S3-13.
103. Pfaller MA, Castanheira M, Messer SA, et al. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Micr Infec Dis 2010;68:278-83.
104. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;20:133-63.
105. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009;9:259-70.
106. Qian Q, Jutila MA, VanRooijen N, et al. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 1994;152:5000-8.
107. Quintin J, Asmar J, Matskevich AA, et al. The Drosophila Toll pathway controls but does not clear Candida glabrata infections. J Immunol 2013;190:2818-27.
108. Rai MN, Balusu S, Gorityala N, et al. Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence. PLoS Pathog 2012; 8:e1002863.
109. Rai MN, Sharma V, Balusu S, et al. An essential role for phosphatidylinositol 3-kinase in the inhibition of phagosomal maturation, intracellular survival and virulence in Candida glabrata. Cell Microbiol 2015;17:269-87.
110. Roetzer A, Gabaldon T, Schuller C. From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogen. FEMS Microbiol Lett 2011;314:1-9.
111. Roetzer A, Gratz N, Kovarik P, et al. Autophagy supports Candida glabrata survival during phagocytosis. Cell Microbiol 2010;12:199-216.
112. Roetzer A, Klopf E, Gratz N, et al. Regulation of Candida glabrata oxidative stress resistance is adapted to host environment. FEBS Lett 2011;585:319-27.
113. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011;11:275-88.
114. Saijo S, Ikeda S, Yamabe K, et al. Dectin-2 recognition of alphamannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010a;32:681-91.
115. Saijo T, Miyazaki T, Izumikawa K, et al. Skn7p is involved in oxidative stress response and virulence of Candida glabrata. Mycopathologia 2010b;169:81-90.
116. Sasada M, Johnston RB, Jr. Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med 1980;152:85-98.
117. Schaller M, Mailhammer R, Grassl G, et al. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002;118:652-7.
118. Schwarzmuller T, Ma B, Hiller E, et al. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PLoS Pathog 2014;10:e1004211.
119. Segal BH, Grimm MJ, Khan AN, et al. Regulation of innate immunity by NADPH oxidase. Free Radical Bio Med 2012;53:72-80.
120. Seider K, Brunke S, Schild L, et al. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 2011;187:3072-86.
121. Seider K, Gerwien F, Kasper L, et al. Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages. Eukaryot Cell 2014;13:170-83.
122. Seider K, Heyken A, Luttich A, et al. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr Opin Microbiol 2010;13:392-400.
123. Silva S, Henriques M, Hayes A, et al. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med 2011;40:421-7.
124. Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012;36:288-305.
125. Smith LM, May RC. Mechanisms ofmicrobial escape fromphagocyte killing. Biochem Soc T 2013;41:475-90.
126. Smith PD, Smythies LE, Shen R, et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol 2011;4:31-42.
127. Soloviev DA, Jawhara S, FonziWA. Regulation of innate immune response to Candida albicans infections by alphaMbeta2-Pra1p interaction. Infect Immun 2011;79:1546-58.
128. Spellberg B, Ibrahim AS, Edwards JE, Jr, et al. Mice with disseminated candidiasis die of progressive sepsis. J Infect Dis 2005;192:336-43.
129. Srivastava VK, Suneetha KJ, Kaur R. A systematic analysis reveals an essential role for high-affinity iron uptake system, haemolysin and CFEM domain-containing protein in iron homoeostasis and virulence in Candida glabrata. Biochem J 2014;463:103-14.
130. Srivastava VK, Suneetha KJ, Kaur R. The mitogen-activated protein kinase CgHog1 is required for iron homeostasis, adherence and virulence in Candida glabrata. FEBS J 2015;282:2142-66.
131. Ueno K, Matsumoto Y, Uno J, et al. Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine. PLoS One 2011;6:e24759. Underhill DM. Phagosome maturation: steady as she goes. Immunity 2005;23:343-4.
132. Underhill DM. Phagosome maturation: steady as she goes. Immunity 2005;23:343-4
133. Uwamahoro N, Verma-Gaur J, Shen HH, et al. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. MBio 2014;5:e00003-14.
134. van 't Wout JW, Linde I, Leijh PC, et al. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol 1988;7:736-41.
135. Vazquez-Torres A, Balish E. Macrophages in resistance to candidiasis. Microbiol Mol Biol R 1997;61:170-92.
136. Vieira OV, Botelho RJ, Grinstein S. Phagosome maturation: aging gracefully. Biochem J 2002;366:689-704.
137. Villena SN, Pinheiro RO, Pinheiro CS, et al. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Cell Microbiol 2008;10:1274-85.
138. Vylkova S, Carman AJ, Danhof HA, et al. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2011;2:e00055-11.
139. Vylkova S, Lorenz MC. Modulation of phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transport. PLoS Pathog 2014;10:e1003995.
140. Wagner D, Maser J, Lai B, et al. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J Immunol 2005;174:1491-500.
141. Weissman Z, Kornitzer D. A family of Candida cell surface haembinding proteins involved in haemin and haemoglobin-iron utilization. Mol Microbiol 2004;53:1209-20.
142. Wellington M, Dolan K, Krysan DJ. Live Candida albicans suppresses production of reactive oxygen species in phagocytes. Infect Immun 2009;77:405-13.
143. Wellington M, Koselny K, Sutterwala FS, et al. Candida albicans triggers NLRP3-mediated pyroptosis in macrophages. Eukaryot Cell 2014;13:329-40.
144. Wells CL, Johnson MA, Henry-Stanley MJ, et al. Candida glabrata colonizes but does not often disseminate from the mouse caecum. J Med Microbiol 2007;56:688-93.
145. West L, Lowman DW, Mora-Montes HM, et al. Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem 2013;288:22006-18.
146. Westwater C, Schofield DA, Nicholas PJ, et al. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis. FEMS Immunol Med Mic 2007;51:134-9.
147. Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2006;2:e35.
148. Woods JP. Knocking on the right door and making a comfortable home: Histoplasma capsulatum intracellular pathogenesis. Curr Opin Microbiol 2003;6:327-31.